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Abstract  
A widely accepted technique to transplant the liver-bowel bloc is first to perform a piggyback 
anastomosis of the donor suprahepatic vena cava to the recipient vena cava; second to restore the 
arterial blood supply through an aortic interposition graft; and third to insure venous drainage of the 
native foregut.  The venous drainage of the native foregut can be restored through an end-to-end 
portocaval anastomosis between the donor infrahepatic vena cava and the recipient portal vein.  
Stenosis of this anastomosis can lead to portal hypertension presenting with upper gastrointestinal 
congestion, bleeding and hypersplenism.  We report the successful treatment of this complication 
using an expanded poly-tetra-fluoro-ethylene-covered stent inserted following balloon angioplasty. 
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Introduction 
Combined liver and intestinal transplantation is considered a valuable treatment option for patients 
suffering from both irreversible intestinal and liver failure (1).  Over the last years, survival after 
combined liver and intestinal transplantation has substantially improved due to standardization of the 
surgical technique and the postoperative care.  However, the surgical procedure remains challenging 
and consists of an en bloc transplantation of a liver-pancreas-duodenal-intestinal graft (2).  As 
illustrated in figure 1, the transplanted organs and the liver in particular are transplanted en bloc onto 
the recipient inferior vena cava which is left intact (piggyback technique).  The arterial blood supply is 
restored through an aortic interposition graft between the recipient suprarenal aorta and the donor 
aortic patch including the origin of the superior mesenteric artery and celiac trunk.  An end-to-end 
anastomosis between the donor infrahepatic vena cava and the recipient portal vein can then be created 
to allow adequate portal drainage of the recipient native foregut (including spleen, pancreas). 
Here, we describe the case of an 11-year-old girl who successfully received a combined liver intestinal 
graft using the aforementioned technique.  Despite the presence of an end-to-end drainage of her 
native foregut to the donor infrahepatic vena cava, she gradually developed congestion of her native 
foregut (including the proximal duodenojejunal anastomosis) with recurrent episodes of upper 
gastrointestinal bleeding, persisting hypersplenism and thrombocytopenia. 
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Case report 
Our patient is an 11-year-old girl who suffered from a neonatal volvulus at the age of 32 weeks.  
Complete necrosis of the whole small bowel and colon ascendens eventually required a total intestinal 
resection leaving her with an ultrashort bowel and a jejunostomy.  The remaining colon was resected 
later (age of 6) due to a refractory diversion colitis following an unsuccessful restoration of the bowel 
continuity between the remaining jejunum and the colon.  Eventually, she was left with a 
duodenostomy.  Due to the short bowel syndrome, she was completely dependent  on total parenteral 
nutrition (TPN)  and gradually developed a biopsy-proven liver cirrhosis with portal hypertension 
including episodes of hemorrhagic/congestive gastro- and duodenopathy at the age of 7. 
Eventually, at the age of 9, she was transplanted with an en bloc liver-pancreas-small and large 
intestinal graft implanted according to Sudan et al (2).  The liver part of the graft was piggyback 
implanted and an arterial reconstruction done using an arterial conduit onto the infrarenal aorta as 
illustrated in Figure 1 .  Because of the en bloc nature of the graft, no biliary nor portal construction 
was necessary.  Adequate drainage of the native foregut (pancreas, stomach and spleen) was achieved 
through an end-to-end anastomosis between the native portal vein and the transplant infrahepatic 
inferior vena cava as advocated by Gondolesi et al (3).  
Her immunosuppression consisted of Tacrolimus (levels ~5 pg/ml), Azathioprine (1 mg/kg) and 
methylprednisolone (4).  At 3, 6 and 13 months post-transplant, recurrent upper gastrointestinal (GI) 
bleeding episodes required readmissions and urgent blood transfusion.  Additionally, intermittent red 
blood loss per stoma remained present.  Biochemical analysis consistently revealed normal 
coagulation parameters except for a progressive thrombocytopenia.  Upper GI endoscopy repeatedly 
revealed diffuse and ulcerative bleeding sites at the level of the proximal anastomosis between the 
native stomach and the transplant jejunum which prompted a surgical intervention.  At the level of the 
duodenojejunostomy, congestion was observed and a new anastomosis was created.  The resection 
specimen showed mucosal erosions and submucosal vascular congestive or thrombosed blood vessels 
compatible with angiodysplasia (Figure 2).  There were no signs of bowel rejection.  After surgery she 
continued to present episodes of upper GI bleedings.  In addition, hypersplenism (splenic diameter of 
17 cm) accompanied by an aggravating thrombocytopenia (which was not present before the 
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transplantation) was observed.  Thrombosis of the native portal vein was repeatedly excluded by 
ultrasound.  Finally, 37 months after the transplantation, an angio-CT scan revealed the presence of a 
filiform aspect of the intrahepatic transplant vena cava distal to a narrowed portocaval anastomosis 
(Figure 3). 
 
Subsequently, the patient was referred for percutaneous, transcatheter management of the thight 
portocaval anastomosis.  Under general anesthesia, a large collateral located close to the chronically 
thrombosed right internal jugular vein was punctured.  Using conventional catheter and guide-wire 
techniques, the portocaval anastomosis and native splenic vein were catheterised.  Pressure 
measurements distally and proximally to the anastomosis were respectively 17 mmHg and 8 mmHg 
resulting in a pressure gradient of 9 mmHg.  Contrast injection through the catheter in the splenic vein 
confirmed the high grade focal stenosis of the portocaval anastomosis and a filiform aspect of the 
donor intrahepatic vena cava.  In addition, multiple collaterals draining into the donor portal vein were 
seen (Figure 4).  These collaterals were located around the surgical duodenojejunal anastomosis.  The 
portocaval stenosis was first predilated with a 3 x 40 mm angioplasty balloon (Wanda, Boston 
Scientific, Natick, MA, USA); subsequently, an expandable poly-tetra-fluoro-ethylene (e-PTFE) 
covered stent (Viabahn, W.L. Gore and Associates, Flagstaff, A, USA) with a diameter of 8 mm and a 
length of 5 cm was inserted over the stenosis and post-dilated with an 8 mm diameter angioplasty 
balloon (Boston Scientific).  Completion angiography showed a restored patency of the intrahepatic 
vena cava and the portocaval anastomosis and disappearance of the splenic venous collaterals draining 
into the donor portal vein (Figure 5).  Pressure measurements proximally and distally to the covered 
stent were respectively 9 and 11 mmHg, resulting in a residual pressure gradient of 2 mmHg.  The 
post-interventional course was uneventful; several control duplex-ultrasound evaluations demonstrated 
a fully patent covered stent (Figure 6) with progressive decrease of the craniocaudal splenic diameter 
up to 15 cm and clinically no recurrent gastrointestinal bleeding was noted over the next 12 months 
after the procedure.  Finally, laboratory analysis revealed a progressive rise of the thrombocyte count 
up to 174,000/l (compared to <50,000/l prior to the e-PTFE insertion). 
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Discussion 
Combined intestinal and liver transplantation has become a life-saving procedure for patients suffering 
from irreversible intestinal and liver failure.  Over the last decades, outcome has improved due to 
substantial improvement in immunosuppression, standardization of the surgical procedure and the 
post-transplant care.  Outcome is nowadays favorable with patient 5 years survival around 55-60% (5).  
In addition, combined liver and intestinal transplantation offers surviving recipients an improved 
quality of life with resumption of oral nutrition and freedom from TPN.  However, the postoperative 
recovery often remains challenging for the transplant physicians taking care of these patients.  
 
This case describes the occurrence of post-transplant hypersplenism and congestive coagulopathy 
leading to upper GI bleeding episodes due to the progressive stenosis of the intrahepatic vena cava of 
the liver component of the graft. 
 
In combined intestinal and liver transplantation, venous drainage of the native foregut and upper 
visceral organs can be done either through an end-to-side anastomosis between the native portal vein 
and the native vena cava or through an end-to-side anastomosis between the native portal vein and the 
donor vena cava (3).  End-to-end anastomoses may have less risk of late development of anastomotic 
strictures in comparison to end-to-side anastomoses (3).  However, this report confirms previous 
observations describing the late development of an end-to-end portocaval anastomotic stenosis in 
combined liver/intestinal transplant recipients (6).  As in the presented case, symptomatic intermittent 
bleeding at the duodenojejunal anastomosis and progressive hypersplenism were present.  Medical 
management including the administration of beta-adrenergic blockade, endoscopic banding or 
sclerotherapy were ineffective.  Surgical management by creating a central shunt or a distal side-to-
side splenorenal shunt has been described by Gondolesi et al (3).  However in the case presented, this 
was regarded a too high risk procedure in the light of the numerous collaterals between the native 
splenic vein and the transplant portal venous system.  Alternatively, a minimally invasive treatment 
option could have been a balloon angioplasty of the portocaval stenosis as described by Fishbein et al 
(6).  However in the latter case, this intervention was unsuccessful, potentially due to elastic recoil of 
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the dilated vessel.  For this reason we decided to insert an e-PTFE-covered stent instead of performing 
a balloon angioplasty alone or insertion of a conventional, bare vascular stent.  In fact, the created 
surgical portocaval shunt resembles an intrahepatic portosystemic shunt.  In analogy to the current 
standard for transjugular intrahepatic portosystemic shunt (TIPS) creation, an e-PTFE-covered stent-
graft was used (7), starting within the proximal splenic vein and ending at the confluence of the 
piggyback anastomosis of the recipient vena cava.  As clearly demonstrated in TIPS-procedures, e-
PTFE-covered stents are associated with better long-term patency compared to bare, vascular stents 
(8). 
In summary, a symptomatic, anastomotic portocaval stenosis developing after combined liver and 
intestinal transplantation can be managed safely and effectively by insertion of an e-PTFE-covered 
stent.  This minimally invasive approach may represent the treatment of choice for this complication.  
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Figure legends 
 
Figure 1: Schematic overview of the en bloc liver/ intestinal transplantation (donor organs depicted in 
bright colours, recipient organs depicted in pale colours) as performed in the case presented.  First, a 
piggyback anastomosis of the donor suprahepatic vena cava (DSVC) to the recipient suprahepatic vena 
cava (RSVC) is performed (anastomosis 1).  Secondly, the arterial blood supply is restored through an 
aortic interposition graft (AIG) between the recipient infrarenal aorta (RAO) and donor aortic patch 
(DAP) including the origin of the superior mesenteric artery and celiac trunk (anastomosis 2).  
Thirdly, an end-to-end anastomosis between the donor infrahepatic vena cava (DIVC) and the 
recipient portal vein (RPV) was created to allow adequate portal drainage of the recipient native 
foregut (including spleen, pancreas) (anastomosis 3).  Continuity of the gastrointestinal tract is 
restored by an anastomosis between the donor jejunum and the recipient duodenum  (anastomosis 4). 
 
Figure. 2: Histologically, very large sized and congested vessels responsible for the recurrent upper 
GI bleeding are present in the mucosa (Figure 2A) and the submucosa (Figure 2B). 
 
Figure 3: A. Axial CT-image depicts hypertrophied venous structures around the duodenojejunal 
anastomosis; B. Coronal reconstructed CT-image clearly demonstrates, besides hypersplenism, the 
filiform aspect of the intrahepatic vena cava distal to a filiform aspect of the intrahepatic vena cava 
distal of a narrowed portocaval anastomosis (arrows).  
 
Figure 4: Digital substraction angiography with the tip of the catheter placed in the native splenic 
vein. A. Early phase images confirm the tight stenosis of the portocaval anastomosis (white arrows); 
B. Mid phase images show multiple, large collaterals draining into the transplant superior mesenteric 
vein and branches (black arrows); C. Late phase images clearly depict the main transplant portal vein 
and its intrahepatic terminal branches (white arrowheads). 
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Figure 5: Digital substraction angiography after insertion of the e-PTFE-covered stent-graft (arrows) 
shows fully patent intrahepatic transplant vena cava and portocaval shunt together with the 
disappearance of the aforementioned collateral network between the native splenic vein and the 
transplant portal venous system. 
 
Figure 6: A. Control gray-scale ultrasound 8 months after the interventional procedure shows the fully 
expanded stent-graft; B. Corresponding color-coded ultrasound confirms a fully patent stented 
portocaval shunt. 
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Figure 2. 
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Figure 3. 
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Figure 4A.
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Figure 4B. 
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Figure 4C. 
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Figure 5. 
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Figure 6A. 
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Figure 6B. 
 
 
